Aayush Food & Herbs Ltd.
Snapshot View

21.05 ▼0%

16 August 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.aayushfoods.com
Market Cap 6.83 Cr.
Enterprise Value(EV) 11.78 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) -6.40 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 32.22 Trailing Twelve Months Ending 2022-03
Book Value / Share 14.64 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.44 Calculated using Price: 21.05
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.32 Cr. 3,245,000 Shares
FaceValue 10
Company Profile
The company is exporting various varieties of finest rice to many countries with major chunk in parts of West Africa. It is strengthening the distribution network through dealers, agents, companies etc. in home country.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-1.17%
1 Month
-17.13%
3 Month
-7.47%
6 Month
-16.96%
1 Year
-29.83%
2 Year
-41.45%
5 Year
-54.09%
10 Year
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 0.31 0.82 -0.62 2.06 7.68 14.04 11.05 10.26 6.44
Return on Capital Employed (%) 0.73 0.50 -0.87 2.08 12.11 23.18 20.33 14.99 14.46
Return on Assets (%) 0.25 0.82 -0.62 1.75 3.05 2.30 1.55 1.52 1.03

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 0 0 4 4 4 5 6 6 7 5
Non Curr. Liab. 0 0 0 1 0 1 12 2 5
Curr. Liab. 0 1 11 37 29 29 27 1
Minority Int.
Equity & Liab. 0 0 4 6 16 43 35 46 36 11
Non Curr. Assets 0 0 0 0 0 1 1 1 1 0
Curr. Assets 0 0 4 5 16 41 34 45 36 11
Misc. Exp. not W/O
Total Assets 0 0 4 6 16 43 35 46 36 11

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 0 0 0 5 100 188 132 127 152 17
Other Income 0 0 0 0 0 0 1 0 0 1
Total Income 0 0 0 5 100 188 133 127 152 18
Total Expenditure 0 0 0 -5 -100 -187 -132 -126 -150 -19
PBIDT 0 0 0 0 1 1 1 2 2 -1
Interest 0 0 0 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 1 1 1 0 -2
Adjusted EPS 0 0 0 0 1 2 2 2 1 -7

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 -4 0 -1 6 -3 -10 6
Cash Fr. Inv. 0 -1 0 0 0
Cash Fr. Finan. 0 4 1 -1 1 11 -9
Net Change 0 0 0 0 4 -2 1 -3
Cash & Cash Eqvt 0 0 0 0 5 3 3 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 51.28 45.74 51.28 51.28 51.28 32.52 32.52 32.52 32.52
Public 48.72 54.26 48.72 48.72 48.72 67.48 67.48 67.48 67.48
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 13 Aug 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed newspaper clippings of the advertisement published on 13th August 2022 regarding the Unaudited Standalone Financial Results of the Company for the quarter ended 30th June 2022 in the following newspapers:1. Delhi edition of Jansatta2. All India Edition of Financial ExpressKindly take the same on your records.
Sat, 13 Aug 2022
Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24 December 2019 regarding submission of Statement of Deviation or Variation from proceeds of public issue/rights issue/preferential issue Qualified Institutions Placement (QIP) etc. The Company hereby declares that the Company has not raised any further fund by the means of Public Issue Rights Issue or Preferential Issue etc.Hence the Statement of deviation(s) or variation(s) is not being provided as it is not applicable to the Company. Kindly take the same on your records.
Fri, 12 Aug 2022
Board Meeting Outcome for Unaudited Standalone Financial Results For The Quarter Ended June 30Th 2022 And Limited Review Report Thereon
With reference to the above we would like to inform you that the Board of Directors of the Company at their board meeting held on Friday 12th August 2022 have inter-alia considered and approved the Unaudited Financial Results of the Company pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the quarter ended June 30th 2022.

A copy of the said Unaudited Financial Results along with the Limited review report thereon by the Statutory Auditors of the Company is enclosed herewith.

The meeting commenced at 02:00 p.m. and concluded at 02:40 p.m.

The extract of the Unaudited Financial Results shall be published in the Newspapers within 48 hours of the conclusion of the meeting.

Kindly take the same on your records.

Technical Scans View Details >>

Tue, 16 Aug 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at Low Opening at Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,443.18 919.00 +0.5%
Divi's Laboratories Ltd. 99,072.87 3,752.00 +0.5%
Cipla Ltd. 83,487.41 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. 71,536.21 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. 62,537.70 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. 53,261.16 1,571.10 -0.2%
Piramal Enterprises Ltd. 45,983.34 1,932.60 +0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.42 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 31.92 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-06 33.44 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.91 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.76 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.33 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-06 24.47 1,932.60 +0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.38 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-06 3.87 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.53 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.52 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.31 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,932.60 +0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,932.60 +0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,932.60 +0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,932.60 +0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,932.60 +0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 919.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,752.00 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,035.35 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,309.00 +0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,326.05 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,571.10 -0.2%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,932.60 +0.3%

FAQ's On Aayush Food & Herbs Ltd.

Can I Buy Aayush Food Shares now?

What is the Share Price of Aayush Food?

What is the Relative Strength Index (RSI) Value of Aayush Food?

What is the Market Capital (MCAP) of Aayush Food?

What are the key metrics to analyse Aayush Food?